{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470631639
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = xi/o
| target = [[Alpha-5 beta-1|α5β1]] [[integrin]]
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 558480-40-3
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 496K5Z02NW
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D06319
<!-- Chemical data -->
| C=6434 | H=9942 | N=1706 | O=2040 | S=52
| molecular_weight = 145.5 kg/mol
}}

'''Volociximab''' (also known as M200) is a [[Chimeric protein|chimeric]] [[monoclonal antibody]] jointly developed by [[PDL BioPharma]] and [[Biogen Idec]] for treatment of a variety of advanced [[solid tumor]]s. It binds to and inhibits the functional activity of [[Alpha-5 beta-1|α5β1]] [[integrin]].<ref>{{cite journal|pmid=19468731|year=2009|last1=Ng|first1=CM|last2=Bai|last3=Takimoto|last4=Tang|last5=Tolcher|title=Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-alpha(5)beta (1) integrin monoclonal antibody (volociximab) in cancer patients|doi=10.1007/s00280-009-1023-8|journal=Cancer chemotherapy and pharmacology|first2=S|first3=CH|first4=MT|first5=AW|volume=65|pages=207–17|issue=2}}</ref>

It is thought to reduce metastases. Early results show potential in [[renal cell cancer]]s.{{cn|date=April 2016}}

==References==
{{reflist}}

==External links==
* [http://www.pdl.com/index.cfm?navId=54 Official website]

{{Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems}}

[[Category:Monoclonal antibodies for tumors]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}